IP Library Granted Patent US 12,207,651
Granted Patent B2
US 12,207,651 · App. 16/500,657 · Granted Jan 28, 2025

Apparatus and methods for irradiating organ perfusates

Inventors: Vanderlei Salvador Bagnato (São Carlos, BR); Marcelo Cypel (Toronto, CA); Shafique Keshavjee (Toronto, CA); Thomas Kenneth Waddell (Toronto, CA); Marcos Theophilo Galasso (Toronto, CA)
Assignees: University Health Network; Universidade de Sao Paulo
A01N1/0294A01N1/0247A61B17/00A61L2/0047A61L2/10A61L2/24A61L2/26A61B2017/00969A61L2202/11A61L2202/121A61L2202/122A61L2202/14A61L2202/182
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,207,651
App. No.
16/500,657
Granted
Jan 28, 2025
Kind
B2
Abstract

Disclosed are apparatuses and methods for irradiating a perfusate. The apparatus includes a tank which defines a first chamber. A separator is located inside the first chamber. The separator defines a second chamber. The first chamber and the second chamber are concentric and have substantially annular cross sections, each having at least one diameter and a substantially common longitudinal axis. A perfusate is introduced into the first chamber by an inlet. A UV radiation-emitting device is disposed inside the second chamber for providing irradiation to the perfusate. Irradiated perfusate is removed from the tank by an outlet. Other apparatuses and systems are described and methods for inactivating micro organisms by performing EVP and irradiating the perfusate.

Claims (25)

1. An ex-vivo organ perfusion system comprising:

an organ chamber for containing an organ during perfusion of the organ;

a perfusion circuit for flowing perfusate to the organ chamber; and

an irradiation system for irradiating perfusate flowing through the perfusion circuit, the irradiation system comprising:

an apparatus comprising:

a first unit comprising side panels,

a second unit pivotally mounted on the first unit such that the second unit is moveable with respect to the first unit to open and close the apparatus, and

at least one radiation source mounted on at least one of the first and second units; and

a receptacle positioned in a chamber defined by the second and first units, wherein the receptacle is a continuous tube configured for flowing perfusate through the chamber for the at least one radiation source to irradiate the perfusate as the perfusate flows through the continuous tube, wherein the continuous tube comprises an inlet and an outlet and a constant diameter body portion extending from the inlet to the outlet, and wherein each of the side panels of the first unit defines a groove adapted to support the continuous diameter body portion of the receptacle.

2. The ex-vivo organ perfusion system of claim 1 , wherein the at least one radiation source comprises an ultraviolet lamp.

3. The ex-vivo organ perfusion system of claim 1 , further comprising safety sensors for detecting when the second unit is moved, such that the sensors detect when the irradiator is open and/or closed and for preventing the system from being inadvertently activated while the second unit is open.

4. The ex-vivo organ perfusion system of claim 1 , wherein at least one radiation source is mounted on each of the first and second units.

5. The ex-vivo organ perfusion system of claim 2 , wherein the ultraviolet lamp comprises one of: ultraviolet-A, ultraviolet-B and ultraviolet-C.

6. The ex-vivo organ perfusion system of claim 3 , wherein the safety sensors comprise sensing plates positioned on the first and second units.

7. The ex-vivo organ perfusion system of claim 1 , wherein ends of the inlet and outlet of the receptacle are machined for fitting external tubes to the ends.

8. The ex-vivo organ perfusion system of claim 1 , wherein the continuous tube is a quartz tube.

9. The ex-vivo organ perfusion system of claim 8 , wherein a wall thickness of the quartz tube is between 12.6 mm and 30.2 mm.

10. The ex-vivo organ perfusion system of claim 1 , wherein a joint between the first unit and the second unit bisects the apparatus.

11. The ex-vivo organ perfusion system of claim 1 , wherein the first unit and the second unit comprise an equal number of the one or more radiation sources.

12. The ex-vivo organ perfusion system of claim 1 , further comprising:

a male connector comprising a first tube-receiving opening configured to receive the inlet of the continuous tube to connect the inlet to the perfusion circuit; and

a female connector comprising a second tube-receiving opening configured to receive the outlet of the continuous tube to connect the outlet to the perfusion circuit.

13. The irradiation system of claim 12 , wherein:

the male connector comprises a first stop-flow pin configured to prevent the perfusate from flowing from the perfusion circuit into the inlet of the continuous tube, and

the female connector comprises a second stop-flow pin configured to prevent the perfusate from flowing into the perfusion circuit from the outlet of the continuous tube.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: GALASSO, MARCOS T; KESHAVJEE, SHAFIQUE; WADDELL, THOMAS K; CYPEL, MARCELO
To: UNIVERSITY HEALTH NETWORK
Reel/Frame 052673/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: CYPEL, MARCELO; GALASSO, MARCOS T; KESHAVJEE, SHAFIQUE; WADDELL, THOMAS K
To: UNIVERSITY HEALTH NETWORK
Reel/Frame 052673/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: BAGNATO, VANDERLEI SALVADOR
To: UNIVERSIDADE DE SAO PAULO
Reel/Frame 052286/0234 →
Continuity (2)
Provisional Application 62481523 · Apr 4, 2017
Related Publication 20200253195A1 · Aug 13, 2020
References Cited (48)
US 5128043A · Wildermuth · 1992 [cited by applicant]
US 6447720B1 · Horton, III et al. · 2002 [cited by applicant]
US 6899355B2 · Klein · 2005 [cited by examiner]
US 6972415B2 · Schaible et al. · 2005 [cited by applicant]
US 7425272B2 · Butters · 2008 [cited by examiner]
US 7687045B2 · Lu · 2010 [cited by examiner]
US 7888656B2 · Freedgood · 2011 [cited by applicant]
US 7993580B2 · Anderle · 2011 [cited by applicant]
US 20030049809A1 · Kaiser · 2003 [cited by examiner]
US 20070202485A1 · Nees et al. · 2007 [cited by applicant]
US 20100056643A1 · Bachynsky et al. · 2010 [cited by applicant]
US 20140334974A1 · Rasooly · 2014 [cited by examiner]
US 20180070583A1 · Paul et al. · 2018 [cited by applicant]
US 20190033419A1 · Golay · 2019 [cited by examiner]
US 20200138015A1 · Bagnato et al. · 2020 [cited by applicant]
CA 2373673C · 2011 [cited by applicant]
CN 1320014A · 2001 [cited by applicant]
CN 1565654A · 2005 [cited by applicant]
CN 100369633C · 2008 [cited by applicant]
CN 101360522A · 2009 [cited by applicant]
CN 102241427A · 2011 [cited by applicant]
CN 102361823A · 2012 [cited by applicant]
CN 204910182U · 2015 [cited by applicant]
WO 1988005261A1 · 1988 [cited by applicant]
WO WO8805261A · 1988 [cited by examiner]
WO 2016090498A1 · 2016 [cited by applicant]
WO 2016207335A1 · 2016 [cited by applicant]
Galasso, M. et al., “Inactivating Hepatitis C Virus in Donor Lungs Using Light Therapies During Normothermic Ex Vivo Lung Perfusion.” Nature Communications, 2019, 12 pages. [cited by applicant]
Khan, B. et al., “Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.” American Journal of Transplantation, 2017, vol. 17, pp. 1129-1131. [cited by applicant]
Inci, I. et al., “Ex Vivo Reconditioning of Marginal Donor Lungs Injured by Acid Aspiration.” The Journal of Heart and Lung Transplantation, 2008, vol. 27, No. 11, pp. 1229-1236. [cited by applicant]
Nakajima, D. et al., “Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury.” The Journal of Heart and Lung Transplantation, 2017, vol. 3… [cited by applicant]
Machuca, T.N. et al., “Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion.” DCDD Lung Transplantation and EVLP. American Journal of Transplantatio… [cited by applicant]
Machuca, T.N. et al., “Injury-Specific Ex Vivo Treatment of the Donor Lung: Pulmonary Thrombolysis Followed by Successful Lung Transplantation.” American Journal of Respiratory and Critical Care Medicine, 2013; vol. 188… [cited by applicant]
Mohr, H. et al., “A Novel Approach to Pathogen Reduction in Platelet Concentrates Using Short-Wave Ultraviolet Light.” Transfusion, 2009, vol. 49, No. 12, pp. 2612-2624. [cited by applicant]
Steinmann, E. et al., “Two Pathogen Reduction Technologies-Methylene Blue Plus Light and Shortwave Ultraviolet Light-Effectively Inactivate Hepatitis C Virus in Blood Products.” Transfusion, 2013, vol. 53, No. 5, pp. 10… [cited by applicant]
Floyd, R. A. et al., “Methylene Blue Photoinactivation of RNA Viruses.” Antiviral Research, 2004, vol. 61, No. 3, pp. 141-151. [cited by applicant]
Müller-Breitkreutz, K, et al., “Hepatitis C and Human Immunodeficiency Virus RNA Degradation By Methylene Blue/Light Treatment of Human Plasma.” Journal of Medical Virology, 1998, vol. 56, No. 3, pp. 239-245. [cited by applicant]
Bachmann, B. et al., “Target Structures for HIV-1 Inactivation by Methylene Blue and Light.” Journal of Medical Virology, 1995, vol. 47, No. 2, pp. 172-178. [cited by applicant]
Smith, D. B. et al., “Variation of the Hepatitis C Virus 5' Non-Coding Region: Implications for Secondary Structure, Virus Detection and Typing.” Journal of General Virology, 1995, vol. 76, No. 7, pp. 1749-1761. [cited by applicant]
Wakita T., “Isolation of JFH-1 Strain and Development of an HCV Infection System.” Hepatitis C: Methods and Protocols, Second Edition, vol. 510, Humana Press, 2009, pp. 305-327. [cited by applicant]
Extended European Search Report dated Mar. 15, 2021, directed to EP Application No. 18780312.7; 11 pages. [cited by applicant]
International Search Report and Written Opinion dated Jun. 12, 2018, directed to International Application No. PCT/CA2018/050400; 14 pages. [cited by applicant]
Notification of The First Office Action dated Oct. 14, 2020, directed to CN Application No. 201880030158.X; 18 pages. [cited by applicant]
European Patent Application No. EP18780312, Supplementary Partial European Search Report, dated Dec. 2, 2020, 4 pages. [cited by applicant]
Examination Report No. 1 dated Jun. 30, 2022, directed to AU Application No. 2018247584; 6 pages. [cited by applicant]
Bagnato et al., U.S. Office Action mailed Jan. 18, 2023, directed to U.S. Appl. No. 16/593,314; 14 pages. [cited by applicant]
Bagnato et al., U.S. Office Action mailed Oct. 24, 2023, directed to U.S. Appl. No. 16/593,314; 20 pages. [cited by applicant]
Bagnato et al., U.S. Office Action dated May 24, 2024, directed to U.S. Appl. No. 16/593,314; 21 pages. [cited by applicant]